Page results
-
This page provides information about food and drink which may affect your ileostomy output.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain and spine. This treatment may also be referred to as whole central nervous system (CNS) or cranio-spinal radiotherapy.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0508 - Lynch syndrome clinical pathway
-
FOI/2023/0509 - Immunoglobulin treatments
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0516 - Maternity management system
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0523 - Treatment on Nivolumab